Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00735124 · ClinicalTrials.gov registry record · Phase 2
Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy
A Phase 2 study, sponsored by University of Oklahoma.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00735124 is a Phase 2 study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 5 participants.
The verdict
NCT00735124, a Phase 2 study, was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The study will investigate the effects of single dose pre-operative oral dose of gabapentin (1200) on post -operative pain scores and oral analgesic requirements.
Interventions
- OTHER placebo
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-11-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00735124
The ClinicalTrials.gov registry entry for NCT00735124 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00735124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00735124 about?
NCT00735124 is a clinical study titled "Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy". The study will investigate the effects of single dose pre-operative oral dose of gabapentin (1200) on post -operative pain scores and oral analgesic requirements.
What is the current status of trial NCT00735124?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2008-11-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00735124?
The interventions under investigation include: placebo (OTHER), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT00735124?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.